CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Clover Health Investments, Corp. /De quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q4 2023.
  • Clover Health Investments, Corp. /De Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $33.1M, a 15.2% decline year-over-year.
  • Clover Health Investments, Corp. /De Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $141M, a 14.2% decline year-over-year.
  • Clover Health Investments, Corp. /De annual Share-based Payment Arrangement, Expense for 2023 was $141M, a 14.2% decline from 2022.
  • Clover Health Investments, Corp. /De annual Share-based Payment Arrangement, Expense for 2022 was $164M, a 0.36% increase from 2021.
  • Clover Health Investments, Corp. /De annual Share-based Payment Arrangement, Expense for 2021 was $164M, a 2213% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $141M $33.1M -$5.96M -15.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $147M $33.1M -$9.57M -22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $156M $36.1M -$5.82M -13.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $162M $38.6M -$2.02M -4.98% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $164M $39.1M +$7.92M +25.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $156M $42.6M -$4.16M -8.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $161M $41.9M -$1.1M -2.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $162M $40.6M -$2.07M -4.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $164M $31.2M +$29.1M +1364% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $135M $46.8M +$45.3M +3020% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $89.4M $43M +$41.6M +2825% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $47.8M $42.7M +$40.7M +2060% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7.08M $2.13M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $1.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.47M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.98M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.